Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
Cancer Research
|
September 29, 1998
Constitutive and antibody-induced internalization of prostate-specific membrane antigen
H Liu, A K Rajasekaran, P Moy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1985
Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer
C L Finstad, C Cordon-Cardo, N H Bander, et al.
British Journal of Haematology
|
March 1, 1993
High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer
G Gastl, M Plante, C L Finstad, et al.
The Urologic Clinics of North America
|
November 1, 1987
Newer diagnostic techniques for bladder cancer
H B Carter, J B Amberson, N H Bander, et al.
Cancer Research
|
October 4, 2000
In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
P M Smith-Jones, S Vallabahajosula, S J Goldsmith, et al.
The Journal of Urology
|
September 1, 1985
Human renal cell carcinoma xenograft: morphology, growth and chemosensitivities
J Fleischmann, W D Heston, N H Bander, et al.
Cancer Research
|
June 26, 1999
Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma
V Kolenko, R G Uzzo, R Bukowski, et al.
The Journal of Experimental Medicine
|
March 1, 1989
Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression
D M Nanus, S A Ebrahim, N H Bander, et al.
The Journal of Biological Chemistry
|
November 5, 1987
DNA-mediated gene transfer of a human cell surface 170-kilodalton glycoprotein. Evidence for association with an endogenous murine protein
R R Kantor, N H Bander, C L Finstad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1989
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2
J C Wang, A Walle, A Novogrodsky, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
Cancer Research
|
September 29, 1998
Constitutive and antibody-induced internalization of prostate-specific membrane antigen
H Liu, A K Rajasekaran, P Moy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1985
Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer
C L Finstad, C Cordon-Cardo, N H Bander, et al.
British Journal of Haematology
|
March 1, 1993
High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer
G Gastl, M Plante, C L Finstad, et al.
The Urologic Clinics of North America
|
November 1, 1987
Newer diagnostic techniques for bladder cancer
H B Carter, J B Amberson, N H Bander, et al.
Cancer Research
|
October 4, 2000
In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
P M Smith-Jones, S Vallabahajosula, S J Goldsmith, et al.
The Journal of Urology
|
September 1, 1985
Human renal cell carcinoma xenograft: morphology, growth and chemosensitivities
J Fleischmann, W D Heston, N H Bander, et al.
Cancer Research
|
June 26, 1999
Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma
V Kolenko, R G Uzzo, R Bukowski, et al.
The Journal of Experimental Medicine
|
March 1, 1989
Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression
D M Nanus, S A Ebrahim, N H Bander, et al.
The Journal of Biological Chemistry
|
November 5, 1987
DNA-mediated gene transfer of a human cell surface 170-kilodalton glycoprotein. Evidence for association with an endogenous murine protein
R R Kantor, N H Bander, C L Finstad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1989
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2
J C Wang, A Walle, A Novogrodsky, et al.
Page
of 8